Share-based Payment Arrangement, Expense of T2 Biosystems, Inc. from 31 Dec 2012 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
T2 Biosystems, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2012 to 30 Sep 2024.
  • T2 Biosystems, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $215,000, a 75% decline year-over-year.
  • T2 Biosystems, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $2,802,000, a 39% decline year-over-year.
  • T2 Biosystems, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4,389,000, a 32% decline from 2022.
  • T2 Biosystems, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6,463,000, a 8.4% decline from 2021.
  • T2 Biosystems, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7,057,000, a 81% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

T2 Biosystems, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $2,802,000 $215,000 -$660,000 -75% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $3,462,000 $196,000 -$711,000 -78% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $4,173,000 $1,580,000 -$216,000 -12% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $4,389,000 $811,000 -$232,000 -22% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
Q3 2023 $4,621,000 $875,000 -$479,000 -35% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $5,100,000 $907,000 -$614,000 -40% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $5,714,000 $1,796,000 -$749,000 -29% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q4 2022 $6,463,000 $1,043,000 -$489,000 -32% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $6,952,000 $1,354,000 -$1,069,000 -44% 01 Jul 2022 30 Sep 2022 10-Q 15 Nov 2023 2023 Q3
Q2 2022 $8,021,000 $1,521,000 -$288,000 -16% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $8,309,000 $2,545,000 +$1,252,000 +97% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023 2023 Q1
Q4 2021 $7,057,000 $1,532,000 +$555,000 +57% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $6,502,000 $2,423,000 +$1,588,000 +190% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $4,914,000 $1,809,000 +$865,000 +92% 01 Apr 2021 30 Jun 2021 10-Q 16 Aug 2022 2022 Q2
Q1 2021 $4,049,000 $1,293,000 +$150,000 +13% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $3,899,000 $977,000 -$104,000 -9.6% 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q3 2020 $4,003,000 $835,000 -$317,000 -28% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $4,320,000 $944,000 -$340,000 -26% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $4,660,000 $1,143,000 -$777,000 -40% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $5,437,000 $1,081,000 -$1,423,000 -57% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $6,860,000 $1,152,000 -$881,000 -43% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $7,741,000 $1,284,000 -$2,590,000 -67% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $10,331,000 $1,920,000 +$563,000 +41% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $9,768,000 $2,504,000 +$1,478,000 +144% 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 $8,290,000 $2,033,000 +$813,000 +67% 01 Jul 2018 30 Sep 2018 10-Q 18 Nov 2019 2019 Q3
Q2 2018 $7,477,000 $3,874,000 +$2,543,000 +191% 01 Apr 2018 30 Jun 2018 10-Q 02 Aug 2019 2019 Q2
Q1 2018 $4,934,000 $1,357,000 +$229,000 +20% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $4,705,000 $1,026,000 -$142,000 -12% 01 Oct 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
Q3 2017 $4,847,000 $1,220,000 +$122,000 +11% 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018 2018 Q3
Q2 2017 $4,725,000 $1,331,000 +$131,000 +11% 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 $4,594,000 $1,128,000 -$136,000 -11% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q4 2016 $4,730,000 $1,168,000 +$14,000 +1.2% 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
Q3 2016 $4,716,000 $1,098,000 -$224,000 -17% 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2017 2017 Q3
Q2 2016 $4,940,000 $1,200,000 +$345,000 +40% 01 Apr 2016 30 Jun 2016 10-Q 04 Aug 2017 2017 Q2
Q1 2016 $4,595,000 $1,264,000 +$542,000 +75% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1
Q4 2015 $4,053,000 $1,154,000 +$558,000 +94% 01 Oct 2015 31 Dec 2015 10-K 19 Mar 2018 2017 FY
Q3 2015 $3,495,000 $1,322,000 +$770,000 +139% 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016 2016 Q3
Q2 2015 $2,725,000 $855,000 +$589,000 +221% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 $2,136,000 $722,000 +$483,000 +202% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q4 2014 $1,653,000 $596,000 01 Oct 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
Q3 2014 $552,000 +$439,000 +388% 01 Jul 2014 30 Sep 2014 10-Q 04 Nov 2015 2015 Q3
Q2 2014 $266,000 +$171,000 +180% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015 2015 Q2
Q1 2014 $239,000 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1
Q3 2013 $113,000 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014 2014 Q3
Q2 2013 $95,000 01 Apr 2013 30 Jun 2013 10-Q 19 Sep 2014 2014 Q2

T2 Biosystems, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $4,389,000 -$2,074,000 -32% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
2022 $6,463,000 -$594,000 -8.4% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $7,057,000 +$3,158,000 +81% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $3,899,000 -$1,538,000 -28% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2022 2021 FY
2019 $5,437,000 -$4,331,000 -44% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $9,768,000 +$5,063,000 +108% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY
2017 $4,705,000 -$25,000 -0.53% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
2016 $4,730,000 +$677,000 +17% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
2015 $4,053,000 +$2,400,000 +145% 01 Jan 2015 31 Dec 2015 10-K 19 Mar 2018 2017 FY
2014 $1,653,000 +$1,075,000 +186% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 $578,000 +$175,000 +43% 01 Jan 2013 31 Dec 2013 10-K 09 Mar 2016 2015 FY
2012 $403,000 01 Jan 2012 31 Dec 2012 10-K 04 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.